top of page
Buscar

New paper accepted on ACS Pharmacology & Translational Science

  • medorglab
  • 24 de abr.
  • 1 min de leitura

Atualizado: há 3 dias

Our latest paper was accepted today in ACS Pharmacology & Translational Science, reporting a small molecule that stabilizes both wild-type and R273H mutant p53. The compound selectively reacts with Cys141 via nucleophilic aromatic substitution, highlighting a novel covalent activator for targeting p53.

 
 
 

Comments


Copyright © 2022 | Medicinal Organic Chemistry Group by EA Lopes

bottom of page